Lei Zhang1,Hai-yan Li2,Ke-fang Fan1,Xiu-li Han1,Chun-yan Hu1,Xiao-min Wang2
1. Innovation Center, Beijing GoodWill Information Technology Co. Ltd., Beijing, 100085 China 2. Department of Neurobiology, Beijing Institute for Neuroscience, Capital Medical University, Key Laboratory of Neurodegenerative Diseases of Ministry of Education of China, Beijing 100069, China
摘要:Biobanks are unified resources that include bio specimens, phenotype data, molecular information generated from the specimens. It plays an irreplaceable role in the studies of human disease prediction, diagnosis and treatment. The emergence and development of the translational medicine has posed an increasing requirement to the bio samples resources. Biobanks are evolving from single centered to multi centered and national scale. As the foundation to the translational medicine, biobanks need to be improved, so to fulfill the bio sample types, contents, sample scales, sample standardization, quality control, ethic protection and resource sharing requirements posed by the translational medicine.
出版日期: 2015-04-22
引用本文:
Lei Zhang,Hai-yan Li,Ke-fang Fan,Xiu-li Han,Chun-yan Hu,Xiao-min Wang. Biobank and translational medicine[J]. 转化医学研究, 2011, 1(2): 44-55.
